TYP tryptamine therapeutics limited

Ann: Exopharm Gains US Patent for LEAP Technology, page-7

  1. 1,507 Posts.
    lightbulb Created with Sketch. 300
    My issue isn't with the delays, it's with Dixon telling shareholders that a deal is around the corner and no further CRs would be required. I don't mind enthusiasm but I also want realistic timelines and market updates without any fluff. Until I see a deal penned down on paper, I'll sit out just in case another surprise CR comes out of the woodwork due to delays or whatever else.
    GLTAH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.2¢
Change
0.001(3.23%)
Mkt cap ! $44.44M
Open High Low Value Volume
3.1¢ 3.2¢ 3.0¢ $18.55K 599.0K

Buyers (Bids)

No. Vol. Price($)
2 401281 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 105602 1
View Market Depth
Last trade - 14.56pm 16/07/2025 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.